- Participation in the international guidelines for sepsis management.
- Covid-19: description of pathophysiology of critical Covid-19 and evaluation of treatments (CIBERESUCICOVID).
- Application of personalized medicine for the critically ill patient.
- Identification of Sepsis biomarkers using the Sepsis Biobank located in VHIR.
- Implementation of RCTs for evaluation of new treatments for Sepsis.
- National leadership on projects of prevention of nosocomial infections.
- Improvements in the support of the patient with acute respiratory failure: from mechanical ventilation to ECMO.
- Evaluation of new strategies for advance monitoring of patients with acute respiratory failure.
Group Leader
Ricard Ferrer Roca
Principal Investigator (PI)
Ricard Ferrer Roca, Juan Carlos Ruiz Rodríguez, Xavier Nuvials Casals, Oriol Roca Gras, Adolf Ruiz Sanmartin, Jordi Riera del Brío
Researchers
Raquel Albertos Martell, Rosa Alcaraz Peñarrocha, José Alonso Fajardo, Eduard Argudo Serra, Camilo Bonilla Rojas, Oriol Caritg Cirera, Luis Chiscano Camon, Sofia Contreras Medina, Alejandro Cortes Herrera, Alexandra Cortina Gutierrez, Candido Diaz Lagares, Marina García García de Acilu, Alejandra Garcia Roche, Judit Garriga Segarra, César Laborda Soriano, Carolina Maldonado Toral, Martinez Gonzalez Daniel, María Martínez Martínez, Abraham Mera Olivares, Andrés Pacheco Reyes, Elisabeth Papiol Gallofre, Marcos Pérez Carrasco, Rosa María Gràcia Gozalo, Isabel Porta Pampalona, Vicent Ribas Ripoll, Mariel Rojas Lora, Judith Sacanell Lacasa, Anna Sánchez Corral, Manel Santafé Colomina, Manuel Sosa Garay, Joaquim Serra Vich, Noemi Varga.
PhD Students
Eduard Argudo Serra, Jaume Baldirà Gonzalez de Irujo, Jesus Caballero López, Berta Caralt, Luis Chiscano Camon, Alexandra Cortina Gutierrez, Marina Garcia de Acilu, Elisabeth Papiol Gallofré, Carlos Ernetso Marrero Eligio, María Martínez Martínez, Judit Sacanell Lacasa, Adolf Ruiz Sanmartin.
Nursing and Technical Staff
Vanessa Casares Rodríguez, Mateu Torres Bonnin, Kenya Sanchez Villanueva, Cyntia Alegre Miranda, Elisabet Gallart Vive, Anna Casas Cubells.
67
PUBLICATIONS
638
IMPACT FACTOR
9.52
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E, Li J, Mirza S, Vines D, Elshafei AA, Scott BJ, Weiss T, Kaur R, Harnois LJ, Miller A, Cerda F, Klein A, Burd JR, Posa-Kearney K, Trump M, Jackson J, Oetting T, Greenwood M, Hazel L, Kingery L, Mogri I, Morris L, Moon JY, Garnett J, Jia S, Nelson K, McNicholas B, Cosgrave D, Giacomini C, Laffey J, Brennan A, Judge C, Kernan M, Kelly C, Ranjan R, Casey S, O'Connell K, Newell E, Gallagher D, Nichol A, Curley G, Estrada MI, Garcia-Salcido R, Vargas-Obieta A, Aguirre-Avalos G, Aguirre-Diaz SA, Alcantar-Vallin L, Alvarado-Padilla M, Chavez-Pena Q, Lopez-Pulgarin JA, Mijangos-Mendez JC, Marin-Rosales M, Garcia-Alvarado JE, Baltazar-Gonzalez OG, Gonzalez-Guerrero MC, Gutierrez Ramirez PG, Pavlov I, Gilman S, Plamondon P, Roy R, Jayaraman D, Shahin J, Ragoshai R, Kaur A, Campisi J, Dahine J, Perron S, Achouri S, Racette R, Kulenkamp A, Roca O, Pacheco A, Garcia-de-Acilu M, Masclans JR, Dot I, Perez Y, Bodet-Contentin L, Garot D, Ehrmann S, Mercier E, Salmon Gandonniere C, Morisseau M, Jouan Y, Darwiche W, Legras A, Guillon A, Tavernier E, Dequin PF, Tellier AC, Reignier J, Lascarrou JB, Seguin A, Desmedt L, Canet E, Guitton C, Marnai R, Callahan JC, Landais M, Chudeau N, Darreau C, Tirot P, Saint Martin M, Le Moal C, Nay MA, Muller G, Jacquier S, Prat G, Bailly P, Ferriere N, Thille AW, Frat JP, Dellamonica J, Saccheri C, Buscot M, Plantefeve G, Contou D, Roux D, Ricard JD, Federici L, Zucman N, Freita Ramos S, Amouretti M, Besset S, Gernez C, Delbove A, Voiriot G, Elabbadi A, Fartoukh M, Nseir S, Preau S, Favory R, Pierre A, Sement A, Terzi N, Sigaud F, Candille C, Turbil E, Maizel J, Brault C, Zerbib Y, Joret A, Daubin C, Lefebvre L, Giraud A, Auvet A, Vinsonneau C, Marzouk M, Quenot JP, Andreu P, Labruyere M, Roudaut JB, Aptel F, Boyer A, Boyer P, Lacherade JC, Hille H, Bouteloup M, Jeannot M, Feller M, Grillet G, Levy B, Kimmoun A
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial.
Lancet Respir Med. 2021 Dec;9(12):1387-1395
DOI: 10.1016/S2213-2600(21)00356-8
IF: 30.70
Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Lancet Infect Dis. 2021 Feb;21(2):226-240
DOI: 10.1016/S1473-3099(20)30796-9
IF: 25.07
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Moller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.
Intensive Care Med. 2021 Nov;47(11):1181-1247
DOI: 10.1007/s00134-021-06506-y
IF: 17.44
Mauri T, Foti G, Fornari C, Grasselli G, Pinciroli R, Lovisari F, Tubiolo D, Volta CA, Spadaro S, Rona R, Rondelli E, Navalesi P, Garofalo E, Knafelj R, Gorjup V, Colombo R, Cortegiani A, Zhou JX, D'Andrea R, Calamai I, Vidal Gonzalez A, Roca O, Grieco DL, Jovaisa T, Bampalis D, Becher T, Battaglini D, Ge H, Luz M, Constantin JM, Ranieri M, Guerin C, Mancebo J, Pelosi P, Fumagalli R, Brochard L, Pesenti A
Sigh in Patients With Acute Hypoxemic Respiratory Failure and ARDS: The PROTECTION Pilot Randomized Clinical Trial.
Chest. 2021 Apr;159(4):1426-1436
DOI: 10.1016/j.chest.2020.10.079
IF: 9.41
Rodríguez A, Ruiz-Botella M, Martín-Loeches I, Jimenez Herrera M, Solé-Violan J, Gómez J, Bodí M, Trefler S, Papiol E, Díaz E, Suberviola B, Vallverdu M, Mayor-Vázquez E, Albaya Moreno A, Canabal Berlanga A, Sánchez M, Del Valle Ortíz M, Ballesteros JC, Martín Iglesias L, Marín-Corral J, López Ramos E, Hidalgo Valverde V, Vidaur Tello LV, Sancho Chinesta S, Gonzáles de Molina FJ, Herrero García S, Sena Pérez CC, Pozo Laderas JC, Rodríguez García R, Estella A, Ferrer R; COVID-19 SEMICYUC Working Group.
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain.
Crit Care. 2021 Jul 6;25(1):235
DOI: 10.1186/s13054-021-03487-8
IF: 9.10
Circulating DNA as a non-invasive biomarker after lung transplantation. (ACITRA study)
Principal Investigator: CO-PI: Jordi Riera del Brío
Agency: Instituto de Salud Carlos III
Funding: 159.720€
Period: 2018-2022
Transcriptomic, epigenetic and functional characterization of patients with secondary hemophagocytic syndrome
Principal Investigator: CO-PI: Adolfo Ruiz Sanmartin
Agency: Instituto de Salud Carlos III
Funding: 117.370€
Period: 2019-2023
Study of the contamination of surfaces and personal protective equipment by patients with severe respiratory infection by coronavirus 2 (SARS-CoV-2) treated with high flow oxygen therapy through nasal cannula
Principal Investigator: Oriol Roca Gas
Agency: Instituto de Salud Carlos III
Funding: 63.000€
Period: 2020-2021
PHITBAC “Nanophotonic biosensors for diagnosis and clinical management of bacterial infections at the point of care”. CO-PI: Ricard Ferrer Roca, Juan Carlos Ruiz Rodriguez . Funding agency: Ministerio de Ciencia e Innovación-MICINN.
Principal Investigator: CO-PI: Ricard Ferrer Roca, Juan Carlos Ruiz Rodriguez
Agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 115.970€
Period: 2021-2024
Heecap: innovative solution that provides non invasive electrical stimulation to prevent diaphragm atrophy in patients under mechanical ventilation
Principal Investigator: Oriol Roca Gas
Agency: Fundació
Funding: 100.000€
Period: 2021-2024